Dual roles and potential applications of exosomes in HCV infections
Authors:
Open Access
- 12 December 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1044832
Abstract
The hepatitis C virus (HCV) causes severe liver diseases, including hepatitis, liver cirrhosis, and hepatocellular carcinoma, which have high morbidity and mortality. Antibody targeting receptor-mediated HCV infections have limited therapeutic benefits, suggesting that the transmission of HCV infections is possibly mediated via receptor-independent mechanisms. Exosomes are membrane-enclosed vesicles with a diameter of 30–200 nm, which originate from the fusion of endosomal multivesicular bodies with the plasma membrane. Accumulating evidence suggests that exosomes have a pivotal role in HCV infections. Exosomes can transfer viral and cellular bioactive substances, including nucleic acids and proteins, to uninfected cells, thus spreading the infection by masking these materials from immunological recognition. In addition, exosomes originating from some cells can deliver antiviral molecules or prompt the immune response to inhibit HCV infection. Exosomes can be used for the diagnosis of HCV-related diseases, and are being presently evaluated as therapeutic tools for anti-HCV drug delivery. This review summarizes the current knowledge on the dual roles and potential clinical applications of exosomes in HCV infections.Keywords
Funding Information
- National Natural Science Foundation of China (ZD2021049)
This publication has 62 references indexed in Scilit:
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resourceHepatology, 2013
- The ins and outs of hepatitis C virus entry and assemblyNature Reviews Microbiology, 2013
- Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cellsProceedings of the National Academy of Sciences, 2013
- Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate ImmunityCell Host & Microbe, 2012
- HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III InterferonsGastroenterology, 2012
- Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi)Gut, 2011
- Chemokine antagonism in chronic hepatitis C virus infectionJournal of Clinical Investigation, 2011
- A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C InfectionPLOS ONE, 2010
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences, 2008
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999